| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11030-018-9886-4 |
| P698 | PubMed publication ID | 30390186 |
| P50 | author | Omidreza Firuzi | Q44553925 |
| Najmeh Edraki | Q51258097 | ||
| Mehdi Khoshneviszadeh | Q64176736 | ||
| P2093 | author name string | Ramin Miri | |
| Sara Ranjbar | |||
| P2860 | cites work | A short history of voltage-gated calcium channels | Q24670360 |
| Safety of anti-inflammatory treatment--new ways of thinking | Q28167016 | ||
| T-type calcium channels contribute to colonic hypersensitivity in a rat model of irritable bowel syndrome | Q28241278 | ||
| New insights into TGF-beta-Smad signalling | Q28260517 | ||
| T-type calcium channels in neuropathic pain | Q28272254 | ||
| Stereoselectivity at the calcium channel: opposite action of the enantiomers of a 1,4-dihydropyridine | Q28336221 | ||
| Presynaptic CaV3.2 Channels Regulate Excitatory Neurotransmission in Nociceptive Dorsal Horn Neurons | Q30422994 | ||
| Synthesis and SAR of b-annulated 1,4-dihydropyridines define cardiomyogenic compounds as novel inhibitors of TGFβ signaling. | Q30529635 | ||
| 1,4-Dihydropyridine derivatives with T-type calcium channel blocking activity attenuate inflammatory and neuropathic pain. | Q31170459 | ||
| New tacrine-dihydropyridine hybrids that inhibit acetylcholinesterase, calcium entry, and exhibit neuroprotection properties | Q33353245 | ||
| Applications of multicomponent reactions to the synthesis of diverse heterocyclic scaffolds | Q33398592 | ||
| The cyclooxygenase isoforms: structural insights into the conversion of arachidonic acid to prostaglandins | Q33778070 | ||
| Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials | Q33912750 | ||
| Small molecule-mediated TGF-β type II receptor degradation promotes cardiomyogenesis in embryonic stem cells | Q34292182 | ||
| Involvement of oxidative stress in Alzheimer disease | Q34545547 | ||
| Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease | Q34988301 | ||
| Overcoming Multidrug Resistance in Cancer: An Update on the Clinical Strategy of Inhibiting P-Glycoprotein | Q35113667 | ||
| Diabetic neuropathy enhances voltage‐activated Ca2+ channel activity and its control by M4 muscarinic receptors in primary sensory neurons | Q35341725 | ||
| Calcium dysregulation in Alzheimer's disease: recent advances gained from genetically modified animals | Q36241923 | ||
| Medicinal chemistry of combretastatin A4: present and future directions. | Q36488159 | ||
| Dihydropyridines: evaluation of their current and future pharmacological applications | Q37591584 | ||
| Novel 5-oxo-hexahydroquinoline derivatives: design, synthesis, in vitro P-glycoprotein-mediated multidrug resistance reversal profile and molecular dynamics simulation study. | Q37652854 | ||
| Novel 1, 4-dihydropyridines for L-type calcium channel as antagonists for cadmium toxicity. | Q37721674 | ||
| Amyloid-β and tau — a toxic pas de deux in Alzheimer's disease | Q37824813 | ||
| Calcium-permeable ion channels in pain signaling | Q38175134 | ||
| Targeting the TGFβ pathway for cancer therapy. | Q38274752 | ||
| The modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decade | Q38305824 | ||
| Design, synthesis and biological evaluation of 5-oxo-1,4,5,6,7,8 hexahydroquinoline derivatives as selective cyclooxygenase-2 inhibitors | Q38627873 | ||
| Analgesic effect of a broad-spectrum dihydropyridine inhibitor of voltage-gated calcium channels | Q38842798 | ||
| Cytotoxic and antimicrobial evaluations of novel apoptotic and anti-angiogenic spiro cyclic 2-oxindole derivatives of 2-amino-tetrahydroquinolin-5-one | Q38911539 | ||
| Cytotoxic and multidrug resistance reversal activities of novel 1,4-dihydropyridines against human cancer cells | Q38936012 | ||
| Advances in structure-based drug discovery of carbonic anhydrase inhibitors | Q38991378 | ||
| Design, synthesis and molecular modeling of pyrazole-quinoline-pyridine hybrids as a new class of antimicrobial and anticancer agents | Q39017376 | ||
| Novel brominated quinoline and pyrimidoquinoline derivatives as potential cytotoxic agents with synergistic effects of γ-radiation | Q39286731 | ||
| Hexahydroquinolines are antimalarial candidates with potent blood-stage and transmission-blocking activity | Q39552647 | ||
| Synthesis and in vitro anticancer evaluation of some novel hexahydroquinoline derivatives having a benzenesulfonamide moiety | Q39626604 | ||
| In vitro anticancer screening and radiosensitizing evaluation of some new quinolines and pyrimido[4,5-b]quinolines bearing a sulfonamide moiety | Q39671527 | ||
| Synthesis and biological evaluation of 2-amino-7,7-dimethyl 4-substituted-5-oxo-1-(3,4,5-trimethoxy)-1,4,5,6,7,8-hexahydro-quinoline-3-carbonitrile derivatives as potential cytotoxic agents | Q39781207 | ||
| Synthesis of some novel quinolines and pyrimido [4,5-b] quinolines bearing A sulfonamide moiety as potential anticancer and radioprotective agents | Q39996433 | ||
| Synthesis of 6-amino-1,4-dihydropyridines that prevent calcium overload and neuronal death | Q40095365 | ||
| Editorial: multidrug resistance in cancer: pharmacological strategies from basic research to clinical issues | Q40513732 | ||
| Insulin resistance and non-insulin-dependent diabetes mellitus: cellular and molecular mechanisms | Q40618017 | ||
| Dyslipidemia in non-insulin-dependent diabetes mellitus | Q40697538 | ||
| QSAR Modeling of COX -2 Inhibitory Activity of Some Dihydropyridine and Hydroquinoline Derivatives Using Multiple Linear Regression (MLR) Method | Q41894079 | ||
| The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes | Q42098787 | ||
| Design, Synthesis and Biological Evaluation of New 1, 4-Dihydropyridine (DHP) Derivatives as Selective Cyclooxygenase-2 Inhibitors | Q42172358 | ||
| Calcium modulators of the anellated dihydropyridine type. Synthesis and pharmacologic action | Q42194078 | ||
| Synthesis of new nonclassical acridines, quinolines, and quinazolines derived from dimedone for biological evaluation | Q42918523 | ||
| Design and synthesis of 2,4-disubstituted polyhydroquinolines as prospective antihyperglycemic and lipid modulating agents | Q43062592 | ||
| Studies on calcium antagonist activities of 2-ethyl-3-carbmethoxy-4-aryl- 5-oxo-6,6-dimethyl-1,4,5,6,7,8-hexahydroquinoline derivatives | Q43859700 | ||
| Microwave-Assisted Synthesis and Spasmolytic Activity of 4-Indolylhexahydroquinoline Derivatives | Q44461253 | ||
| Novel quinolines and pyrimido[4,5-b]quinolines bearing biologically active sulfonamide moiety as a new class of antitumor agents | Q44708675 | ||
| Design and synthesis of methyl 2-methyl-7,7-dihalo-5-phenyl-2-azabicyclo[4.1.0]hept-3-ene-4-carboxylates with calcium channel antagonist activity | Q44907248 | ||
| Studies on 3-diethylaminocarbonyl-1,4,5,6,7,8-hexahydroquinoline derivatives and their calcium channel antagonistic activities in vitro. | Q45041914 | ||
| Utility of 4-(5,5-dimethyl-3-oxo-cyclohex-1-enylamino)benzenesulfonamide in the synthesis of novel quinolines as possible anticancer and radioprotective agents | Q46212678 | ||
| Condensed 1,4-dihydropyridines with various esters and their calcium channel antagonist activities | Q46242705 | ||
| Discovery of Coumarin–Dihydropyridine Hybrids as Bone Anabolic Agents | Q46289293 | ||
| Synthesis, QSAR and calcium channel modulator activity of new hexahydroquinoline derivatives containing nitroimidazole. | Q46621895 | ||
| Synthesis, configuration, and calcium modulatory properties of enantiomerically pure 5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylates | Q46805747 | ||
| Synthesis and calcium modulatory activity of 3-alkyloxy-carbonyl-4-(disubstituted)aryl-5-oxo-1,4,5,6,7,8-hexa-hydroquinoline derivatives | Q46906349 | ||
| Hexahydroquinolinones with calcium-modulatory effects--synthesis and pharmacologic action | Q46946612 | ||
| Vinylogous and coupled hexahydroquinolinones and dihydropyridines with calcium-modulating effects | Q46960640 | ||
| Benzofuran-dihydropyridine hybrids: A new class of potential bone anabolic agents | Q47448520 | ||
| Transforming growth factor beta (TGF-β) isoforms in wound healing and fibrosis | Q48067747 | ||
| Synthesis and evaluation of 1,4-dihydropyridine derivatives with calcium channel blocking activity. | Q48918282 | ||
| Design, synthesis, cytotoxicity evaluation and docking studies of 1,2,4-triazine derivatives bearing different arylidene-hydrazinyl moieties as potential mTOR inhibitors. | Q49196595 | ||
| Synthesis and Antimicrobial Activity of Some New N‐Substituted Quinoline Derivatives of 1H‐Pyrazole | Q50043792 | ||
| Synthesis, pharmacological evaluation and molecular docking of pyranopyrazole-linked 1,4-dihydropyridines as potent positive inotropes | Q53113337 | ||
| Upregulation of T-type Ca2+ Channels in Primary Sensory Neurons in Spinal Nerve Injury | Q54292498 | ||
| Synthesis of some 1,4,5,6,7,8-hexahydroquinoline derivatives and their calcium antagonistic activity | Q54650357 | ||
| Ueber die Synthese pyridinartiger Verbindungen aus Acetessigäther und Aldehydammoniak | Q56440284 | ||
| Synthesis and evaluation of analogs of (Z)-1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene as potential cytotoxic and antimitotic agents | Q68173089 | ||
| The optical isomers of the 1,4-dihydropyridine BAY K 8644 show opposite effects on Ca channels | Q68942777 | ||
| Dihydropyridines, a new group of strongly effective coronary therapeutic agents | Q70651987 | ||
| Quantitative structure-activity relationships for 1,4-dihydropyridine calcium channel antagonists (nifedipine analogues): a quantum chemical/classical approach | Q72865192 | ||
| Synthesis and calcium antagonistic activity of 2,6,6-trimethyl-3-carbomethoxy(ethoxy)-4-aryl-1,4,5,6,7,8-hexahydroquinoline derivatives | Q73504794 | ||
| Intrathecal administration of Cav3.2 and Cav3.3 antisense oligonucleotide reverses tactile allodynia and thermal hyperalgesia in rats following chronic compression of dorsal root of ganglion | Q79368090 | ||
| Synthesis and spectral investigation of some new hetaryl-substituted hydroquinolinone derivatives | Q86312726 | ||
| Synthesis, characterization and pharmacological screening of some novel 5-imidazopyrazole incorporated polyhydroquinoline derivatives | Q87557480 | ||
| Tetrahydroquinolinone derivatives as potent P-glycoprotein inhibitors: design, synthesis, biological evaluation and molecular docking analysis | Q90949162 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 471-508 | |
| P577 | publication date | 2018-11-02 | |
| P1433 | published in | Molecular Diversity | Q3319469 |
| P1476 | title | 5-Oxo-hexahydroquinoline: an attractive scaffold with diverse biological activities | |
| P478 | volume | 23 |
| Q64962051 | Direct Enantiomeric Resolution of Seventeen Racemic 1,4-Dihydropyridine-Based Hexahydroquinoline Derivatives by HPLC. | cites work | P2860 |
Search more.